Question 1 · 232 words written
1. क्या इस अध्ययन में डॉ. सिंह की भागीदारी उचित है? अपना औचित्य सिद्ध कीजिए। 2. क्या डॉ. सिंह हितों के टकराव से जुड़े हैं? यदि हां, तो ऐसे टकराव की प्रकृति क्या है? इसका शमन कैसे किया जा सकता है? 3. यदि उनके नाम पहले से ही शेयर नहीं होते तथा उक्त अध्ययन के संचालन के एवज में शेयर का प्रस्ताव किया गया होता तो हितों के टकराव की प्रकृति किस प्रकार अलग होती?
Opening · no separate opening
None written.
Body · points and prose
(Stakeholders are: Doctor, Agency, Patient, Society, Investigating)
- The participation of Dr. Singh has following issues: a) Lack of transparent display of the treatment - neither patient nor the physician will be knowledgeable of the drug.
- This is the clear violation of rights of patients to have clear information. b) Luring by money and reputation: By offering amount per patient, it is the lure of money power. c) Not fully in accordance to the doctor Ethics. But it has certain benefits by participation - a) Treatment and saving of life of patients ensued. b) Right to life as well as the effective treatment. The participation comes with benefits but lacks the ethical aspect of patients' Right to Information, ethical behavioural of doctor - whom patients treat equivalent to God and lured by money and reputation.
- Conflict of interest : a. Personal monetary gains verses the crisis of conscience of fair play. b. Reputation ensured in short term verses cheating by avoiding accountability, full information to patients (being stockholder). c. Availability of drug to small section verses the public service motive and ethics of doctors. It can be mitigated by proper dialogue with the firm to ensure that the treatment is given to all patients but by the information of that investigation process without any favour.
- The nature of conflict between - to gain the position and no accountability since earlier you were not the stock holder.
Close · no separate close
None written.